Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2005 | 04-2004 | 04-2003 | 04-2002 | 04-2001 | |
| Sales | 0 | 1,999 | 2,006 | 2,148 | 2,210 |
| Cost of Goods | N/A | 1,889 | 1,823 | 1,885 | 1,973 |
| Gross Profit | N/A | 111 | 183 | 263 | 237 |
| Operating Expenses | 106 | 1,214 | 1,152 | 1,295 | 1,679 |
| Operating Income | -106 | -215 | -146 | -147 | -469 |
| Interest Expense | 0 | 0 | 0 | 2 | 4 |
| Other Income | 0 | 0 | 0 | 2 | 4 |
| Pre-tax Income | -106 | -215 | -146 | -147 | -469 |
| Income Tax | N/A | N/A | N/A | N/A | 208 |
| Net Income Continuous | -106 | -215 | -146 | -147 | -677 |
| Net Income Discontinuous | -141 | N/A | N/A | N/A | N/A |
| Net Income | $-247 | $-215 | $-146 | $-147 | $-677 |
| EPS Basic Total Ops | -0.24 | -0.24 | -0.24 | -0.24 | -1.08 |
| EPS Basic Continuous Ops | -0.12 | -0.30 | -0.21 | -0.21 | -0.95 |
| EPS Basic Discontinuous Ops | -0.12 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.24 | -0.24 | -0.24 | -0.24 | -1.08 |
| EPS Diluted Continuous Ops | -0.12 | -0.30 | -0.21 | -0.21 | -0.95 |
| EPS Diluted Discontinuous Ops | -0.12 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-57 | $-167 | $-98 | $-97 | $-409 |